DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Schlumberger M, Tahara M, Wirth LJ. et al.
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
New Engl J Med 2015;
372: 621-630
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.